Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update

Simon Otter; J.R. Cyer

doi:10.1002/msc.56

Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update

Simon Otter, J.R. Cyer

University of Brighton

Research output: Contribution to journal › Article › peer-review

Abstract

This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNF) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.

Original language	English
Pages (from-to)	51-59
Number of pages	9
Journal	Musculoskeletal Care
Volume	2
Issue number	1
DOIs	https://doi.org/10.1002/msc.56
Publication status	Published - Mar 2004

Keywords

Podiatry
rheumatoid arthritis
anti-TNF therapy

Access to Document

10.1002/msc.56Licence: Unspecified

http://www3.interscience.wiley.com/cgi-bin/fulltext/112435632/PDFSTARTLicence: Unspecified

Cite this

@article{86958b7bf0d94b59825da29cfb794c05,

title = "Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update",

abstract = "This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNF) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.",

keywords = "Podiatry, rheumatoid arthritis, anti-TNF therapy",

author = "Simon Otter and J.R. Cyer",

year = "2004",

month = mar,

doi = "10.1002/msc.56",

language = "English",

volume = "2",

pages = "51--59",

journal = "Musculoskeletal Care",

issn = "1478-2189",

number = "1",

}

TY - JOUR

T1 - Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update

AU - Otter, Simon

AU - Cyer, J.R.

PY - 2004/3

Y1 - 2004/3

N2 - This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNF) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.

AB - This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNF) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.

KW - Podiatry

KW - rheumatoid arthritis

KW - anti-TNF therapy

U2 - 10.1002/msc.56

DO - 10.1002/msc.56

M3 - Article

SN - 1478-2189

VL - 2

SP - 51

EP - 59

JO - Musculoskeletal Care

JF - Musculoskeletal Care

IS - 1

ER -

Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update

Abstract

Keywords

Access to Document

Fingerprint

Cite this